Source: Annual Congress 2005 - Protocols in the critically ill patient
Disease area: Respiratory critical care, Respiratory infections



Rating:

Share or cite this content

Citations should be made in the following way:
S. Ewig (Bochum, Germany). Antibiotic use. Annual Congress 2005 - Protocols in the critically ill patient

Member's Comments

No comment yet.

Related content which might interest you: Optimising the duration of antibiotic therapy for ventilator-associated pneumonia Source: Eur Respir Rev 2007; 16: 40-44 Year: 2007 Hospital-acquired pneumonia: microbiological data and potential adequacy of antimicrobial regimens Source: Eur Respir J 2002; 20: 432-439 Year: 2002 Relevance of correct antibiotic choice in community-acquired pneumonia (CAP) Source: Annual Congress 2005 - Community-acquired pneumonia: clinical approaches Year: 2005 Determinants of prescription and choice of empirical therapy for hospital-acquired and ventilator-associated pneumonia Source: Eur Respir J 2011; 37: 1332-1339 Year: 2011 The impact of a delay in intensive care unit admission for community-acquired pneumonia Source: Eur Respir J 2010; 36: 826-833 Year: 2010 Effect of giving antibiotics within 4 hours to patients with community-acquired pneumonia on mortality, length of stay and critical care admission Source: International Congress 2016 – Community-acquired pneumonia: from prevention to treatment Year: 2016 Efficacy of ceftobiprole in intensive care unit (ICU) patients with hospital-acquired pneumonia (HAP) Source: International Congress 2014 – Respiratory infections: inflammation and treatment Year: 2014 Relationship between tracheotomy and ventilator-associated pneumonia: a case control study Source: Eur Respir J 2007; 30: 314-320 Year: 2007 VAP: approach to therapy Source: Eur Respir Mon 2011; 53: 36-47 Year: 2011 Antibiotic treatment for nosocomial pneumonia Source: ISSN=1025-448x, ISBN=1-904097-32-4, page=211 Year: 2004 Cost-effective antibiotic management of community acquired pneumonia Source: ISSN=1025-448x, ISBN=1-904097-32-4, page=198 Year: 2004 Pharmacokinetic optimisation of β-lactams for the treatment of ventilator-associated pneumonia Source: Eur Respir Rev 2007; 16: 45-49 Year: 2007 Evaluation of severe pneumonias in the ICU of a tertiary center in Southern India Source: Annual Congress 2005 - Diagnosis and prognosis of ventilator associated pneumonia: the clinical track Year: 2005 Effect of adherence to guidelines on mortality, length of stay and critical care admission in community-acquired pneumonia Source: International Congress 2016 – Community-acquired pneumonia: risk classes and management issues Year: 2016 Emergency treatment of communityacquired pneumonia Source: ISSN=ISSN 1025-448x, ISBN=ISBN 1-904097-42-1, page=183 Year: 2006 The treatment costs of ventilator associated pneuomonia in intensive care unit Source: International Congress 2015 – Immunodepression and severe pneumonia Year: 2015 Appropriateness and delay to initiate therapy in ventilator-associated pneumonia Source: Eur Respir J 2006; 27: 158-164 Year: 2006 A population-based study of the costs of care for community-acquired pneumonia Source: Eur Respir J 2004; 23: 610-616 Year: 2004 Impact of a intensive care unit (ICU) programme to improve compliance with hand hygiene in ventilator associated pneumonia (VAP) incidence Source: Annual Congress 2009 - Ventilator-associated pneumonia, severe community-acquired pneumonia and healthcare associated pneumonia Year: 2009 Importance of appropriate initial antibiotic therapy and de-escalation in the treatment of nosocomial pneumonia Source: Eur Respir Rev 2007; 16: 33-39 Year: 2007